The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers. 2012

John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
Department of Psychiatry, McGill University, Montréal, Québec, Canada.

Dopamine neurotransmission influences approach toward rewards and reward-related cues. The best cited interpretation of this effect proposes that dopamine mediates the pleasure that commonly accompanies reward. This hypothesis has received support in some animal models and a few studies in humans. However, direct assessments of the effect of transiently increasing dopamine neurotransmission have been largely limited to the use of psychostimulant drugs, which elevate brain levels of multiple neurotransmitters in addition to dopamine. In the present study we tested the effect of more selectively elevating dopamine neurotransmission, as produced by administration of the immediate dopamine precursor, L-DOPA (0, 100/25, 200/50 mg, Sinemet), in healthy human volunteers. Neither dose altered positive mood. The results suggest that dopamine neurotransmission does not directly influence positive mood in humans.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006262 Health The state of the organism when it functions optimally without evidence of disease. Individual Health,Normalcy,Normality,Health, Individual,Normalcies,Normalities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006805 Human Experimentation The use of humans as investigational subjects. Human Research Subject Protection,Experimentation, Human
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
December 1978, Activitas nervosa superior,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
January 1993, Fundamental & clinical pharmacology,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
January 2002, BMC psychiatry,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
November 2013, Cancer chemotherapy and pharmacology,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
January 2014, Cancer chemotherapy and pharmacology,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
September 2002, Journal of clinical pharmacology,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
January 2020, Current clinical pharmacology,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
June 2013, Gait & posture,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
February 2005, Cephalalgia : an international journal of headache,
John Liggins, and Robert O Pihl, and Chawki Benkelfat, and Marco Leyton
January 2020, Frontiers in psychology,
Copied contents to your clipboard!